City National Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
City National Bank's XBI Position: Q3 2015 in Review
City National Bank reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5.4% in Q3 2015, selling an estimated $1.37M and leaving 304,689 shares worth $19M. The position accounts for 0.16% of the portfolio, ranked #140.
City National Bank first reported a position in XBI in Q2 2015 and has held it in 2 quarters since. The position peaked at $27.1M in Q2 2015. 196 funds tracked by Wall St. Rank hold XBI as of Q3 2015.
- City National Bank held 304,689 shares of State Street SPDR S&P Biotech ETF worth $19M as of Q3 2015.
- City National Bank sold 17,361 State Street SPDR S&P Biotech ETF shares in Q3 2015, an estimated $1.37M.
- State Street SPDR S&P Biotech ETF made up 0.16% of City National Bank's portfolio in Q3 2015, its #140 holding.
- City National Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and has held it in 2 quarters since.
- City National Bank's State Street SPDR S&P Biotech ETF position peaked at $27.1M in Q2 2015.
- 196 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2015.
Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.